Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Shanghai Pharmaceuticals Holding Co Ltd
Operating Expenses
Shanghai Pharmaceuticals Holding Co Ltd
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Operating Expenses
-¥21.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Operating Expenses
-¥26.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-14%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Operating Expenses
-¥7.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Operating Expenses
-¥1.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-14%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Operating Expenses
-¥9.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-14%
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Operating Expenses
-¥6.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-21%
|
See Also
What is Shanghai Pharmaceuticals Holding Co Ltd's Operating Expenses?
Operating Expenses
-21.4B
CNY
Based on the financial report for Mar 31, 2024, Shanghai Pharmaceuticals Holding Co Ltd's Operating Expenses amounts to -21.4B CNY.
What is Shanghai Pharmaceuticals Holding Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-11%
Over the last year, the Operating Expenses growth was 5%. The average annual Operating Expenses growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been -4% over the past three years , -4% over the past five years , and -11% over the past ten years .